SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018527
Filing Date
2020-04-24
Accepted
2020-04-24 16:25:40
Documents
4
Period of Report
2020-06-18
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A myok-def14a_20200618.htm DEF 14A 2205291
2 GRAPHIC gt5pjg2jpiec000001.jpg GRAPHIC 3129
3 GRAPHIC gt5pjg2jpiec000002.jpg GRAPHIC 53127
4 GRAPHIC gt5pjg2jpiec000003.jpg GRAPHIC 40944
  Complete submission text file 0001564590-20-018527.txt   2340663
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37609 | Film No.: 20815395
SIC: 2834 Pharmaceutical Preparations